Qatar University signs MoU with Spanish universities' alliance
| تاريخ الإتاحة | 2025-11-19T08:31:42Z |
| تاريخ النشر | 2022-05-23 |
| الوصف | Qatar University (QU) has signed a memorandum of understanding (MoU) with the 4 Universities Alliance (A4U) — a strategic partnership between four leading Spanish public universities — within the framework of promoting the cooperation between Qatar and Spain in the higher education sector. |
| اللغة | en |
| الناشر | Dar Al Sharq Group |
| License rights | For purposes of private study, scholarship, and research, you may print or download this content. Publication and/or broadcast in any form requires permission from the copyright holder (if any) and University of Qatar. |
| الموضوع | Universities Alliance Spain Hassan Al Derham Pompeu Fabra University University of Barcelona Autonomous University of Madrid Carlos III University of Madrid |
| النوع | Article |
| جريدة | The Peninsula |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
جريدة البننسولا [1318 items ]
وثائق ذات صلة
عرض الوثائق المتصلة بواسطة: العنوان، المؤلف، المنشئ والموضوع.
-
University Social Augmenters Brand Equity: Do University Social Augmenters Possess Brand Characteristics? An Abstract
( Springer Nature , 2019 , Book chapter)Do university social augmenters have brand equity? To answer this question, the study conceptualizes, develops, and empirically examines a model of university social augmenters brand equity (USABE). We define university ... -
How sociable is your university brand? An empirical investigation of university social augmenters' brand equity
( Emerald Group Publishing Ltd. , 2018 , Article)Purpose: The purpose of this paper is to integrate branding and higher education literature to conceptualize, develop, and empirically examine a model of university social augmenters' brand equity. Design/methodology/approach: ... -
Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar
( Elsevier , 2021 , Article)BackgroundPatients having CYP2C19 loss-of-function alleles and receiving clopidogrel are at higher risk of adverse cardiovascular outcomes. Ticagrelor is an effective antiplatelet that is unaffected by the CYP2C19 polymorphism. ...
